KALA BIO, Inc.

KALA

Explore Our Financial Data > Companies > KALA BIO, Inc.
{{popupValue}}
{{popupSubtitle}}
Documentation
Excel
API
Download

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
KALA
CIK0001479419
SIC2834
SectorManufacturing
Industry CategoryPharmaceutical Products
Industry GroupPharmaceutical Preparations

Contact

Address1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Website kalarx.com
Phone781-996-5252
CEOMark T. Iwicki
Employees30

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
RevenueN/A
Pre-Tax Income$-35.84 million
Net Income$-35.84 million
Net Income to Common$-35.84 million
EPS$-5.09
View All
Balance Sheet
Cash$21.10 million
Assets$25.02 million
Liabilities$33.69 million
Common Equity$-8.66 million
Liabilities & Equity$25.02 million
View All
Cash Flow Statement
Net Income$-35.84 million
Cash From Operating Activities$-32.03 million
Cash From Investing Activities$-84,000.00
Cash From Financing Activities$4.01 million
Change in Cash$-28.11 million
View All
Calculations
NOPAT$-26.88 million
EBITDA$-31.83 million
Price to EarningsN/A
Price to BookN/A
ROE3969.10%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

KALA BIO Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

ARLINGTON, Mass., Dec. 05, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA) (“KALA” or the “Company”), today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase of an aggregate of 10,000,000 shares of its common stock (or pre-funded warrants in lieu thereof), at a purchase price of $1.00 per share (or pre-funded warrant in lieu thereof). H.C. Wainwright & Co. acted as the exclusive placement agent for the offe

Article Link

KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

ARLINGTON, Mass., Dec. 04, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA) (“KALA” or the “Company”), today announced that it has entered into definitive agreements for the purchase of an aggregate of 10,000,000 shares of its common stock (or pre-funded warrants in lieu thereof), at a purchase price of $1.00 per share (or pre-funded warrant in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to occur on or about

Article Link

BC-Most Active Stocks

Nu Holdings Ltd. 26,237,161 17.815

Article Link

Top Midday Gainers

Q32 Bio's (QTTB) shares doubled amid heavy trading after the company said Monday it sold alopecia ar

Article Link

BC-Most Active Stocks

Nu Holdings Ltd. 30,838,583 17.56

Article Link